The NHS Plan launched in 2000 advocated a linked antenatal and neonatal screening programme for haemoglobinopathies. Currently screening practices vary widely across the UK and patient sampling is generally performed in a hospital setting. The process is awed and frequently fails to provide accurate and timely information. In this study we demonstrate that organisational changes can improve the ef ciency and quality of screening. The primary care screening process described here has increased partner testing rates and allowed early identi cation of at risk couples.
S
ickle cell and thalassaemia major are recessive disorders affecting large populations worldwide. Many areas in the UK have a high prevalence of these genes within their local populations. Despite several guidelines on the subject 1,2 antenatal screening practices vary greatly across the UK and are awed in several respects. The results of a recent National Con dential Enquiry into thalassaemic births in the UK highlighted this problem demonstrating that 61% of newborns with thalassaemia major resulted from the failure to identify a high-risk couple. Screening delays, inadequate screening policies and laboratory errors were amongst the causes given. 3 Such de ciencies have been noted by others. 4 In the Birmingham area, prior to this project, haemoglobinopathy screening was initiated in hospital antenatal booking clinics late in the rst trimester resulting in delayed identi cation of high-risk couples and low uptake of prenatal diagnosis. This situation is common in many other areas of the UK. 3 To surmount these dif culties we have established a community based screening protocol. Our aim was to streamline the process bringing it forward to enable identi cation of high-risk couples by 13 weeks gestation.
METHODS
This study was performed in the Ladywood area of Birmingham, UK. 42% of the population were from ethnic minority groups, mainly Caribbean (13.6%) and Indian sub-continent (20.7%). Within this population there were approximately 1200 births/year. Universal screening of pregnant women by standard laboratory methods was undertaken. Community midwives screened pregnant women at presentation to their general practitioner (GP) (Figure 1 ). Samples were forwarded and processed within 48 hours by a single laboratory. Positive results were faxed to the haemoglobinopathy counsellors prompting urgent partner sampling and referral of at risk couples to a clinical genetics clinic before 13 weeks gestation. This process therefore is centered around the community midwives, laboratory and haemoglobinopathy counsellors and involves neither GP nor obstetrician in the initial phase. If the couple did not wish to be seen with a view to prenatal diagnosis they would be contacted again three months post delivery to discuss options for future pregnancies. The haemoglobinopathy counsellors inform the neonatal screening service of the high-risk couple and the date of delivery. The study period was between 1 February 2001 to 31 January 2002. The results for the study have been compared to previous year's gures as historical controls. During the control year all women attending the antenatal clinic at Birmingham City Hospital were screened for haemoglobinopathies at booking (16 weeks or later). These samples were processed routinely, haemoglobinopathy counsellors arranged for counselling and partner testing of carriers. High risk couple identi cation was rarely achieved before 20 weeks gestation
RESULTS
There were 1104 pregnant women identi ed for screening. Of these women 21 refused screening (1.9%), 40 samples (3.6%) were not received by the laboratory and accompanying data was incomplete on 15 samples (1.3%). There were 1028 complete data sets for analysis: 56 (75%) partners underwent testing, 19 (25%) had no partner result. The reasons for the failure to partner test were: partner refused test, out of country, no longer with partner, or women would not disclose partners details. 75 women (7.3%) had a positive result (23 b thalassaemia trait, 31 sickle cell trait (AS), 10 haemoglobin C trait, four haemoglobin D trait, seven haemoglobin E trait (AE).
Eleven at risk couples were identi ed by 13 weeks (seven at risk of a child with a sickling disorder, four at risk of a child with b thalassaemia). Of the 11 at risk couples, nine (82%) were referred to discuss antenatal diagnostic procedures by 13 weeks gestation. Two couples declined to be seen by the clinical geneticists. Two additional at risk couples presented to their GPs at 16 weeks gestation and were referred to clinical geneticists by 20 weeks. Of the at risk couples referred only one woman (at risk of a child with b thalassaemia) underwent chorionic villous sampling and was found to be carrying a normal female.
Pregnancy outcomes for high-risk couples were as follows: one miscarried, one stillbirth (no haemoglobinopathy status available, couple at risk of homozygous sickle cell disease child) one b thalassaemia major, one Sb thalassaemia, two AS (twins), two AE, and three with normal adult haemoglobin.
For historical data see Table 1 . In 1999-2000 3129 women attended the hospital booking clinic at 16 weeks gestation. The number of women screened is greater in the historical control year because the clinic covers a greater area than Ladywood alone; 130 women were subsequently found to have a positive haemoglobinopathy screen, and 39 (30%) partners underwent testing. Only one couple attended the clinical genetics clinic for antenatal diagnosis. This couple, who had previously had a child with thalassaemia, self referred at 12 weeks.
DISCUSSION
We have demonstrated that it is possible to greatly accelerate the process of haemoglobinopathy screening and that organisational changes, with minimal nancial input, can dramatically improve the ef ciency of the screening process. Based upon previous studies demonstrating that at risk couples are more likely to request antenatal diagnosis if counselling is performed early 5 we anticipated an increase in antenatal diagnostic testing. However despite early identication there was a low uptake of antenatal diagnosis.
In comparison to the previous year we have achieved higher rates of partner testing and higher referral rate to a clinical genetics clinic before 13 weeks gestation. Low rates of partner testing in 1999-2000 suggest that several at risk couples may have been missed. The keys to success of this project have been rstly closing the gap between the initial encounter of the pregnant woman with her GP and the screening appointment with the midwifery service, and secondly, prioritising antenatal screening work in the haemoglobinopathy counselling team and laboratory thus speeding up the process. This has been achieved by the development of a multidisciplinary team including a GP, a haemoglobinopathy counsellor, laboratory and midwifery representatives. The only additional staff required during this pilot was a project facilitator (AK) who collated data and educated both primary care staff and community midwives about the project.
Despite the apparent success there are a number of issues that have been highlighted during the course of the study. Firstly, haemoglobinopathy information lea ets were available for patients and informed consent for testing was taken by community midwives but we were unable to demonstrate an improvement in knowledge in the antenatal patient population (data not shown). The likely explanation is that, in general, patients received inadequate information prior to testing. This may re ect the current recruitment crisis in both midwifery and primary care or low levels of haemoglobinopathy knowledge amongst community midwives and GPs. Secondly, poor literacy skills of the patient population may also contribute. To counter this problem we suggest that educational programmes will need to be established for all staff involved in screening. Previous work has shown the bene ts of such an approach. 5 Furthermore, interpretation services need to be responsive and have the capacity to deal with a wide range of languages particularly with increasing populations of asylum seekers present in many cities.
In conclusion we have been able to demonstrate a marked improvement in the quality of antenatal screening during this study. It is intended to 'roll out' this protocol to the rest of the city. A single primary care trust will manage the provision of counselling and sample processing will be centralised. With the forthcoming national screening plan for haemoglobinopathies in mind we suggest this model maybe applicable elsewhere. 
